Free Webinar: Direct Radioisotopic Imaging

ThiswebinarwasrecordedonMay20,2015.

SeminarOverview

SensitiveinvivoluminescentimagingsystemsliketheBrukerIn-VivoXtrememaybeleveragednotonlyfortraditionalbioluminescentimagingapplications,butalsofordetectionofPETradionuclideCherenkovradiation.Cherenkovluminescentimaging(CLI)solutions,relativetotraditionalPETdetectortechnology,provideaninexpensiveapproachtoPETtracerimaging.SomehavespeculatedthatCLItechnologiescouldsupplybroaderaccessformoreresearcherstoperformPETtracerstudies.Still,CLIislimitedinsensitivity(CLbluelightemissionsaresubjecttosignificantscatterintissue)andisnotapplicableforsomeofthemostcommonradioisotopesusedinnuclearmedicine(e.g.99mTc).

TheBrukerIn-VivoXtremesystemprovidesformultimodalX-rayimaging,fluorescenceimaging(FLI),bioluminescence/Cherenkovimaging(BLI/CLI),anddirectradioisotopicimaging(DRI),andistheonlypreclinicalsystemofferingcombinedCLIandDRI.TheIn-VivoXtremeperformsDRIusingaphosphorconversionscreenfordirectdetectionofradionuclidegammarayemissionsandovercomesmanyofthelimitationsofCLI,allowingformoresensitivedetectionsandimagingofabroaderrangeofisotopes.

Whatyouwilldiscover

DuringthiswebinarwewilloverviewthemultimodalcapabilitiesoftheIn-VivoXtreme,highlightingtheapplicationpotentialforDRI.

Whoshouldattend

Researchersinvolvedinpreclinicalnuclearmedicine,small-molecularcompoundstudies,andin-vivoimaging.

Presenter

ToddSasser,PhD
FieldApplicationsScientist
BrukerPreclinicalImaging